Shanel A. Lindsay
Founder and President
Boston-based attorney and patient advocate Shanel Lindsay founded Ardent LLC and invented the precision medicinal cannabis tool, the NOVA™ Decarboxylator, along with Ardent’s suite of wellness and beauty products. Shanel drafted the state of Massachusetts’ adult use cannabis law and is founding member and co-chair of the Northeast Cannabis Coalition and counsel to the Massachusetts Patients Advocacy Alliance. She was recently appointed by the Treasurer to the newly-formed Massachusetts Cannabis Advisory Board, working with the Massachusetts government to develop and implement regulations for the medical and adult use markets. Shanel is dedicated to improving public understanding of cannabis’ medicinal benefits. She is certain that with increased education, research, and reliable clinical data, patients and doctors—even those who have not previously considered cannabis as an option—will discover it is a legitimate, viable, and safe treatment for a wide variety of ailments and conditions.
Shanel completed her undergraduate degree at the University of Pennsylvania before receiving her JD from the Northeastern University School of Law. She began her legal career as a judicial law clerk for the Massachusetts Superior Court, then joined the Boston law firm of Sugarman, Rogers, Barshak & Cohen, where she served as a civil litigator for Fortune 500 companies. Shanel also worked for the Massachusetts State Lottery Commission as Employment Counsel and Director of Human Resources. Learn more about Shanel's journey as a medical cannabis patient, advocate and entrepreneur.
Elizabeth G. Dost
Chief Clinical Officer
Elizabeth Dost is a registered nurse and senior health care executive with more than 20 years experience in the Boston-area health care market. Beth is a Certified Cannabis Nurse and Nominating Committee member of the American Cannabis Nurse Association, and an active member of the Society for Cannabis Clinicians, Americans for Safe Access, Patients Out of Time, and the National Hospice and Palliative Care Organization (NHPCO), where she serves on their speaker’s list. She also is a registered participant of My Compassion and the Medical Cannabis Institute. Prior to joining Ardent as Chief Clinical Officer, Beth was the Vice President and Executive Director of Guardian Hospice and Palliative Care, a non-profit hospice company that drove a culture of compassionate care to all persons and their loved ones seeking end-of-life health services and support. A passionate advocate for patients, her resume also includes; CEO and President of Primary Health Services, Inc., a premier pediatric home care company and nationally recognized provider of home care services to medically complex, fragile children who would otherwise face long-term hospitalization; CCO of a private duty aftercare and eldercare service company; and Director of Clinical Services for a skilled nursing home based hospice company.
Beth was awarded Ernst and Young, Merrill Lynch and Inc. Magazine’s Entrepreneur of the Year in Healthcare, New England Region, and is a member of the elite group Alumni. She has received Special Recognition by the Massachusetts’ Department of Public Health for services provided to a foster child suffering from AIDS, was an invited participant to the US Surgeon General’s Conference in Washington, DC, and is a sought after public speaker on cannabis, leadership, marketing, entrepreneurship, pain management, death and dying with dignity. Notably, Beth was called upon to speak statewide on behalf of all hospices in Massachusetts for the Coalition against Physician Assisted Suicide.
Steven Shelales has been an expert on nutraceutical products for over 17 years. His experience studying nutraceuticals in an academic environment, advising the public on their use, and gathering both empirical evidence and anecdotal data has provided him a keen perspective on the usefulness, validity and limitations of natural therapies. Steven earned his Masters of Science in Medical Laboratory Science and Biotechnology from the University of Rhode Island, summa cum laude, specializing in natural products science, stem cell science and the organismal theory of evolution. His master’s literature review investigated the varied uses of beta glucans from mushroom sources, their potency and their potential uses in the future of medicine.
Steven's research at the University of Rhode Island Pharmacognosy Lab involved studying novel sources of resveratrol, properties of rebaudioside-A and novel separation methods of reb-A from raw crude stevia extract, and the development of fast-dissolving films for nutraceutical delivery. He has broad knowledge of the scientific industry, having worked as a chemist at a chemical manufacturing and processing industrial facility, in quality control in the food industry, and in process development for biopharmaceuticals at a large biotech firm. Steven's primary expertise lies in developing formulations and extracts from raw sources in a variety of delivery forms.